A novel methylation signature predicts radiotherapy sensitivity in glioma
Abstract Glioblastoma (GBM) is the most common and malignant cancer of the central nervous system, and radiotherapy is widely applied in GBM treatment; however, the sensitivity to radiotherapy varies in different patients. To solve this clinical dilemma, a radiosensitivity prediction signature was c...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2020-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-020-77259-9 |